Yeung Heung Yeung, PhD

  • Cancer biology at AnorMed and Genzyme

Lixin Yang

  • 30 years experiences in pharmaceuticals industry

Simon Fricker, PhD

  • Chemistry at Vertex Pharmaceuticals

EXECUTIVE CHAIRMAN

Advisors

  • Immuno-oncology at Aleta, Biogen, and X-Rx

Eric Cheng, MD, MBA

Team

Robert Perni, PhD


Jin (Jim) Wang

  • 20+ years of experience in business development

  • ​Formerly at Johnson and Johnson, ImmunoGen, Anchor, and Oxyrane

  • 15+ years of experience in founding, investing, and managing innovative therapeutic R&D companies

CO-FOUNDER, CBO (PART-TIME)
  • Investment Director at Jianxin Capital

Founder 
CSO 

Management

CORPORATE DEVELOPMENT, COO

WntRx's team is comprised of world-leading cancer researchers and biotech industry innovators whose work lies at the forefront of cancer therapeutics development. Management is guided by distinguished advisors, including industry leaders and highly experienced investors and entrepreneurs.

  • 20+ years of experience in founding, investing, and managing innovative therapeutic R&D companies

Paul D. Rennert, PhD

Yanjun Ma


David Zhu, PhD

John Tagliamonte, MBA

  • President of Venture Leader Group

  • Former President of TEEC Angel Fund 

  • Executive Vice President of Technology and Research, Microsoft